JULIA VARSHAVSKY, PH.D.

OccamPoint

Julia is the founder and managing director of OccamPoint. She has over 15 years of drug development experience spanning areas from drug discovery through commercialization and life-cycle management. During her tenure in the industry, Dr. Varshavsky served in a variety of leadership roles in both large R&D (Eli Lilly, Genentech) and small-to-midsize pharma (Jazz Pharmaceuticals, Corcept Therapeutics) organizations, building and leading Biostatistical, Biometrics and Development teams.

In 2019 Dr. Varshavsky founded OccamPoint, a consortium of drug and combination product development professionals, to aid assessment of investment risk in healthcare and digital health products during due diligence and business development. As a Life Sciences Council member for Springboard Enterprises, Dr. Varshavsky works with peers in finance, legal and investment communities to foster success of female-led healthcare and digital health startups, coaching on a broad range of topics including indication-specific product development, use of AI in patient selection and diagnostics, as well as scalable and efficient data aggregation and sharing strategies.

Dr. Varshavsky holds a Ph.D. in Statistics from Purdue University.